Contact
Please use this form to send email to PR contact of this press release:
Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at ESMO Congress 2017
TO:
Please use this form to send email to PR contact of this press release:
Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at ESMO Congress 2017
TO: